Viewing Study NCT06310317



Ignite Creation Date: 2024-05-06 @ 8:16 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06310317
Status: RECRUITING
Last Update Posted: 2024-03-15
First Post: 2024-03-07

Brief Title: Applied Behavior Analysis With Technologies
Sponsor: Istituto per la Ricerca e lInnovazione Biomedica
Organization: Istituto per la Ricerca e lInnovazione Biomedica

Study Overview

Official Title: Evaluating the Effect of Use of Technologies to Increase the Cognitive Abilities in Children With Autism Spectrum Disorders
Status: RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Applied Behavior Analysis ABA is a therapeutic approach for autism that is based on the principles of behavioral theory learning and positive reinforcement Current research shows that early and intensive ABA intervention is effective in reducing dysfunctional behaviors and promoting learning and enactment of socially appropriate behaviors

In this context new approaches that attempt to integrate advanced technologies can play a key role This experimental protocol aims to test whether the use of advanced technologies such as tablets as part of an intervention for a group of children with autism spectrum disorder ASD is more effective than the traditional approach implemented in a control group of children with ASD The experimental protocol is aimed at enhancing cognitive skills increasing new skills and acquiring functionaladaptive behaviors
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None